Results 131 to 140 of about 55,485 (214)

Management and toxicological analysis of ocular hypertension after EyeCee^® ONE intraocular lens implantation: a case series. [PDF]

BMC Ophthalmol
Bastelica P, Magny R, Poupon J, Sonigo B, Aubert T, Brignole-Baudouin F, Buffault J, Baudouin C, Labbé A.   +8 more
europepmc   +1 more source

Outcomes of a non-diffractive extended depth of focus intraocular lens in patients with well-controlled glaucoma and ocular hypertension. [PDF]

Int J Ophthalmol
Liu JR, Szigiato AA, Harasymowycz P.
europepmc   +1 more source

Cost-effectiveness of monitoring ocular hypertension based on a risk prediction tool. [PDF]

BMJ Open Ophthalmol
Wu H, Gazzard G, King A, Morgan J, Wright D, Crabb DP, Takwoingi Y, Azuara-Blanco A, Watson V, Hernández R.   +9 more
europepmc   +1 more source

A phase III study comparing preservative-free latanoprost eye drop emulsion with preserved latanoprost in open-angle glaucoma or ocular hypertension. [PDF]

Eye (Lond)
Baudouin C, Stalmans I, Bourne R, Larrosa JM, Schmickler S, Seleznev A, Oddone F, Phase III study group.   +7 more
europepmc   +1 more source

Prospective 18-Month Study of Bimatoprost Intracameral Implant in Patients with Open-Angle Glaucoma or Ocular Hypertension in US Clinical Practice. [PDF]

Drugs
Mann E, Kammer JA, Sawhney G, An J, Werts EC, Vera V, Rivas M, Lai H, Sonparote S, Craven ER.   +9 more
europepmc   +1 more source

PEY16 THE PREVALENCE AND COST OF TREATMENT OF PATIENTS TAKING ANTIGLAUCOMA AGENTS FOR GLAUCOMA OR OCULAR HYPERTENSION IN FRANCE

, 2005
GA De Pouvourville, A. Solesse de Gendre, Maud Beillat   +2 more
openalex   +1 more source

Risk Factors for Glaucoma and Ocular Hypertension and Post-Transplant Complications in Keratoconus: A Multivariable Analysis. [PDF]

J Clin Med
Nandzik M, Wylęgała A, Szkodny D, Wróblewska-Czajka E, Wylęgała E, Orzechowska-Wylęgała B.   +5 more
europepmc   +1 more source

Correction: Proteomic and Cytokine Profiling in Plasma from Patients with Normal-Tension Glaucoma and Ocular Hypertension. [PDF]

Cell Mol Neurobiol
Langbøl M, Saruhanian A, Saruhanian S, Tiedemann D, Baskaran T, Vohra R, Rives AS, Moreira J, Prokosch V, Liu H, Lackmann JW, Müller S, Nielsen CH, Kolko M, Rovelt J.   +14 more
europepmc   +1 more source

Microglia depletion leads to increased susceptibility to ocular hypertension-dependent glaucoma. [PDF]

Front Aging Neurosci
Diemler CA, MacLean M, Heuer SE, Hewes AA, Marola OJ, Libby RT, Howell GR.   +6 more
europepmc   +1 more source

MEK Inhibitor-Associated Ocular Hypertension. [PDF]

Ocul Oncol Pathol
Collet DA, Canestraro J, Abou-Alfa GK, Abramson DH, Diamond EL, Francis JH.   +5 more
europepmc   +1 more source